跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
S-3a
首页
药物
S-3a
S-3a
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Substituted polycyclic pyridone derivatives and prodrugs thereof
US 10392406 B2
申请人: SHIONOGI & CO
优先权: 2015
CN
EP
US
11 件公开
Methods for the detection, analysis and isolation of nascent proteins
US 7897335 B2
申请人: AMBERGEN INC
优先权: 2001
US
9 件公开
US 7312060 B2
申请人: AMBERGEN INC
优先权: 2003
US
2 件公开
STAPLED AND STITCHED POLYPEPTIDES AND USES THEREOF
EP 2991665 A4
申请人: HARVARD COLLEGE
优先权: 2013
CN
EP
US
6 件公开
Anti-proliferative compounds, compositions, and methods of use thereof
US 2005222090 A1
申请人: GILEAD SCIENCES INC
优先权: 2004
US
3 件公开
DIAMINE DERIVATIVES
EP 1405852 B9
申请人: DAIICHI SANKYO CO LTD
优先权: 2001
CN
EP
2 件公开
1,5,6,-Substituted-2-Oxo-3-Cyano-1,6a-Diaza-Tetrahydro-Fluoranthenes as Anti-Infective Agents
US 2008167296 A1
申请人: KESTELEYN BART RUDOLF ROMANIE
优先权: 2006
CN
US
2 件公开
ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, AND ELECTRONIC APPLIANCE
EP 3974433 B1
申请人: IDEMITSU KOSAN CO
优先权: 2019
CN
EP
2 件公开
HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION INCLUDING SAME
EP 4223755 A4
申请人: SUMITOMO CHEMICAL CO
优先权: 2020
CN
EP
2 件公开
Novel polypeptide and process for producing the same
US 2008009604 A1
申请人: TANIHARA MASAO
优先权: 2002
US
2 件公开
Interleukin-1beta converting enzyme inhibitors
US 7041696 B2
申请人: PROCTER & GAMBLE
优先权: 2003
US
2 件公开
第 1 / 4 页
上一页
下一页
药物
反馈